Jeffrey S. Wagener - Concepedia

Author

Jeffrey S. Wagener

Also Known As

J S Wagener, J Wagener, J. S. WAGENER, J. S. Wagener, J. Wagener, J.S. Wagener, JEFFREY S. WAGENER, Jeffrey S Wagener, Jeffrey S. Wagener, Jeffrey S. Wagener†

127

Publications

8.5K

Citations

H-Index

135

Concepts

All Affiliations

University of Colorado Denver Case Western Reserve University University of Arizona Pinnacle Clinical Research Rainbow Babies & Children's Hospital

About

Jeffrey S. Wagener is an author at University of Colorado Denver specializing in medicine, pediatrics, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	40	4K
2	Health Sciences	7	7	577
3	Public Health	7	7	649
4	Engineering	1	1	14
5	Social Sciences	1	1	10

Jeffrey S. Wagener

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Early Pulmonary Inflammation in Infants with Cystic Fibrosis Talat Z. Khan, Jeffrey S. Wagener, Thomas Bost, American Journal of Respiratory and Critical Care Medicine	1995	1.2K
Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis Michael W. Konstan, Wayne J. Morgan, Steven M. Butler, The Journal of Pediatrics Advanced Lung DiseaseVentilationPediatricsForced Expiratory VolumePulmonary Physiology	2007	437
Early pulmonary inflammation in infants with cystic fibrosis. T Z Khan, Jeffrey S. Wagener, T Bost, American Journal of Respiratory and Critical Care Medicine InflammationEarly EventsInflammatory Lung DiseaseAirway MacrophagesLung Inflammation	1995	401
Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis Michael W. Konstan, Steven M. Butler, Mary Ellen B. Wohl, The Journal of Pediatrics NutritionBody CompositionPhysiologyClinical NutritionPulmonary Function	2003	389
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis Margaret Rosenfeld, Julia Emerson, Frank J. Accurso, Pediatric Pulmonology	1999	352
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis Ronald L. Gibson, Julia Emerson, Sharon McNamara, American Journal of Respiratory and Critical Care Medicine AntibioticsInhaled TobramycinPediatricsRespiratory InfectionPediatric Lung Disease	2003	314
Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution Michael W. Konstan, Pamela B. Davis, Jeffrey S. Wagener, Human Gene Therapy	2004	295
Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data Gregory S. Sawicki, Edward F. McKone, David J. Pasta, American Journal of Respiratory and Critical Care Medicine	2015	236
Impact of Pseudomonas and Staphylococcus Infection on Inflammation and Clinical Status in Young Children with Cystic Fibrosis Scott D. Sagel, Ronald L. Gibson, Julia Emerson, The Journal of Pediatrics Clinical StatusBacterial InfectionsAntibioticsPediatricsRespiratory Infection	2008	220
Impact of Pregnancy on Women With Cystic Fibrosis Ann McMullen, David J. Pasta, Michael W. Konstan, CHEST Journal InfertilityFertilityMaternal ComplicationReproductive HealthGynecology	2006	171

Page 1